Buspirone in the Management of Agitation and Aggression Associated With Dementia

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
N Herrmann, Goran Eryavec

Abstract

Buspirone, a nonbenzodiazepine anxiolytic, has been shown to decrease aggression in animal models and reduce agitation in a small number of patients with organic brain syndromes. An open pilot study was conducted to assess the usefulness of buspirone in managing agitation and aggression in elderly dementia patients. Sixteen patients, ages 65-89, with various types of dementia associated with severe agitation and aggression were treated with buspirone. Outcome was measured by the Clinical Global Impression Scale. Significant improvement was noted in six patients. Buspirone holds promise as a modestly effective and relatively safe alternative to neuroleptics in the management of agitation and behavioral disturbances associated with dementia. More systematic trials are indicated.

Citations

Jul 1, 1996·Journal of Geriatric Psychiatry and Neurology·M S Lantz, D Marin
Oct 1, 1995·Journal of Geriatric Psychiatry and Neurology·P N TariotI R Katz
Dec 19, 2001·International Journal of Geriatric Psychiatry·J MintzerA Breier
Jan 1, 2003·Expert Review of Neurotherapeutics·Abhilash K Desai, George T Grossberg
Feb 6, 1999·Journal of Clinical Psychopharmacology·J T Apter, L A Allen
Mar 19, 2003·Journal of Geriatric Psychiatry and Neurology·Fadi H RamadanRoger Prior
Nov 5, 2015·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
Aug 31, 1999·The Annals of Pharmacotherapy·P S Shelton, V G Brooks

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here